VYNE Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
VYNE Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • VYNE Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $122K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $122K +$122K Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $151K +$151K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $180K +$180K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $207K +$207K Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $0 $0 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $0 $0 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $0 $0 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $0 $0 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $0 -$1.04M -100% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 -$1.23M -100% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $0 -$1.41M -100% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 -$1.58M -100% Dec 31, 2021 10-K 2022-03-17
Q3 2021 $1.04M -$1.16M -52.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.23M -$1.33M -52.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.41M -$314K -18.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.58M -$111K -6.55% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $2.19M +$1.36M +164% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.56M +$1.57M +160% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.72M +$1.05M +157% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.69M Dec 31, 2019 10-K 2021-03-04
Q3 2019 $830K Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $985K Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $670K Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.